149 related articles for article (PubMed ID: 35633029)
1. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
[TBL] [Abstract][Full Text] [Related]
2. Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database.
Chiappini S; Schifano F
J Clin Psychopharmacol; 2018 Feb; 38(1):72-79. PubMed ID: 29210868
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
[TBL] [Abstract][Full Text] [Related]
4. A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis.
Gouverneur A; Ferreira A; Morival C; Pageot C; Tournier M; Pariente A
Br J Clin Pharmacol; 2021 Oct; 87(10):3971-3977. PubMed ID: 33713370
[TBL] [Abstract][Full Text] [Related]
5. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
6. Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.
Klein L; Bangh S; Cole JB
West J Emerg Med; 2017 Feb; 18(2):243-250. PubMed ID: 28210359
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
8. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis.
Merino D; Gérard AO; Destere A; Askenazy F; Drici MD; Thümmler S
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428541
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-related fatal poisoning, England and Wales, 1993-2013: impact of the withdrawal of thioridazine.
Handley S; Patel MX; Flanagan RJ
Clin Toxicol (Phila); 2016 Jul; 54(6):471-80. PubMed ID: 27023487
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F
Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.
Evoy KE; Teng C; Encarnacion VG; Frescas B; Hakim J; Saklad S; Frei CR
Subst Abuse; 2019; 13():1178221819844205. PubMed ID: 31068753
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Lertxundi U; Erezuma I; Hernandez R; Medrano J; Garcia M; Aguirre C
Int Clin Psychopharmacol; 2019 Mar; 34(2):89-92. PubMed ID: 30531551
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone).
Martínez Martínez L; Olivera Fernández MR; Piñeiro Corrales G
Farm Hosp; 2009; 33(4):224-8. PubMed ID: 19712611
[TBL] [Abstract][Full Text] [Related]
19. Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
Osborn DP; Petersen I; Beckley N; Walters K; Nazareth I; Hayes J
J Psychopharmacol; 2018 Oct; 32(10):1098-1103. PubMed ID: 29938561
[TBL] [Abstract][Full Text] [Related]
20. Safety of antipsychotic drugs: A systematic review of disproportionality analysis studies.
Cepaityte D; Siafis S; Papazisis G
Behav Brain Res; 2021 Apr; 404():113168. PubMed ID: 33581145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]